ICR and Royal Marsden paediatric centre

Our joint Institute of Cancer Research (ICR) and Royal Marsden paediatric experimental cancer medicine centre (ECMC) is an Innovative Therapies for Children with Cancer European Consortium (ITCC) accredited centre. It runs the largest paediatric and adolescent drug development programme in the UK, which leads on national and international trials of molecularly targeted agents and immunotherapies.

With advanced pharmacokinetic, pharmacodynamic and functional imaging capabilities, this centre is one of only a few in Europe to conduct functional imaging biomarker studies in paediatric and teenage and young adult cohorts. Their goal is to improve the five-year survival of childhood and adolescent cancer by accelerating drug development.

There is also an adult centre at the ICR.

Lynley Marshall - Centre lead

Lynley Marshall is Deputy Lead for our network and Paediatric Clinical Research Lead at The Royal Marsden. She also leads the Paediatric and Adolescent Oncology Drug Development Team, focusing on cancer drug development and early-phase clinical trials of experimental therapeutics for high-risk, poor prognosis malignancies. She is passionate about training and mentoring young investigators.

Royal Marsden NHS Foundation Trust

Children and Young People’s Unit

Downs Road

Sutton

Surrey

SM2 5PT

Programme office email:

ecmcadmin@cancer.org.uk